Evolent Health, Inc. (NYSE:EVH – Get Free Report) President Daniel Joseph Mccarthy sold 11,000 shares of the stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $30.00, for a total transaction of $330,000.00. Following the transaction, the president now directly owns 198,333 shares of the company’s stock, valued at approximately $5,949,990. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Evolent Health Price Performance
Shares of NYSE EVH opened at $29.16 on Tuesday. The stock’s 50-day moving average is $26.92 and its two-hundred day moving average is $28.61. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.04 and a quick ratio of 1.04. The company has a market cap of $3.35 billion, a price-to-earnings ratio of -28.59 and a beta of 1.44. Evolent Health, Inc. has a 1-year low of $23.33 and a 1-year high of $36.70.
Institutional Trading of Evolent Health
Large investors have recently made changes to their positions in the company. FMR LLC grew its holdings in Evolent Health by 214.2% during the 1st quarter. FMR LLC now owns 14,641,699 shares of the technology company’s stock worth $461,373,000 after acquiring an additional 9,980,971 shares in the last quarter. RA Capital Management L.P. purchased a new position in Evolent Health in the third quarter valued at $74,520,000. William Blair Investment Management LLC acquired a new stake in Evolent Health in the second quarter valued at $80,930,000. Bellevue Group AG lifted its holdings in Evolent Health by 57.4% during the 2nd quarter. Bellevue Group AG now owns 3,448,322 shares of the technology company’s stock worth $104,484,000 after buying an additional 1,257,175 shares during the last quarter. Finally, Wellington Management Group LLP boosted its position in shares of Evolent Health by 90.8% during the 1st quarter. Wellington Management Group LLP now owns 2,499,435 shares of the technology company’s stock worth $81,107,000 after acquiring an additional 1,189,594 shares in the last quarter.
Wall Street Analyst Weigh In
Evolent Health Company Profile
Evolent Health, Inc, a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management.
- Five stocks we like better than Evolent Health
- How to Invest in Social Media
- The most upgraded stocks in November have two things in common
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Monday.com rocked earnings like it’s the weekend
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Plan to own one retailer? Make it this one
Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.